Beijing Creative Group Co., Ltd. (SHE:002350)

Verve Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	191.23	357.36	279.92	546.83	368.85	409.83
Cash & Short-Term Investments	191.23	357.36	279.92	546.83	368.85	409.83
Cash Growth	-4.96%	27.66%	-48.81%	48.25%	-10.00%	-10.10%
Accounts Receivable	1,023	941.1	850.86	1,020	1,185	1,185
Other Receivables	44.21	32.73	4.81	21.14	12.58	2.45
Receivables	1,067	973.83	855.67	1,042	1,212	1,188
Inventory	418.12	340.02	381.24	400.89	398.7	430.04
Other Current Assets	129.78	104.45	75.6	55.04	75.91	76.32
Total Current Assets	1,807	1,776	1,592	2,044	2,055	2,104
Property, Plant & Equipment	652.12	657.04	612.99	614.49	717.38	755.65
Long-Term Investments	157.36	157.93	244.73	259.02	288.67	164.37
Goodwill	10.21	10.21	16.21	89.24	43.33	46.69
Other Intangible Assets	177.7	181.31	196.26	234.15	176.23	177.63
Long-Term Deferred Tax Assets	51	51.32	53.92	33.09	37.82	32.38
Long-Term Deferred Charges	32.56	33.97	39.42	74.72	45.34	25.45
Other Long-Term Assets	22.95	23.01	4.96	5.2	89	11.18
Total Assets	2,910	2,890	2,761	3,354	3,453	3,317
Accounts Payable	976.31	887.83	687.54	935.92	968.42	882.51
Accrued Expenses	16.47	54.58	54.28	76	54.21	65.2
Short-Term Debt	40.02	55.04	127.11	238.28	236.94	163.57
Current Portion of Long-Term Debt	11.16	6.77	9.81	0.21	-	-
Current Portion of Leases	-	4.59	17.61	16.74	-	-
Current Income Taxes Payable	13.02	4.34	4.58	7.59	9.84	12.28
Current Unearned Revenue	31.7	30.06	31.97	39.08	52.68	71.56
Other Current Liabilities	32.04	36.74	51	40.42	21.86	40.88
Total Current Liabilities	1,121	1,080	983.89	1,354	1,344	1,236
Long-Term Debt	55.36	55.36	-	9.8	-	-
Long-Term Leases	5.03	6.28	16.46	34.06	-	-
Long-Term Unearned Revenue	3.71	3.77	3.88	4.12	13.1	13.32
Long-Term Deferred Tax Liabilities	2.92	2.94	3.59	1.85	6.62	-
Total Liabilities	1,188	1,148	1,008	1,404	1,364	1,249
Common Stock	542.33	542.33	542.33	542.37	542.37	542.37
Additional Paid-In Capital	733.73	733.73	734.99	735.07	731.9	712.9
Retained Earnings	568.78	558.22	519.01	703.07	692.77	622.75
Treasury Stock	-177.52	-145.27	-100.02	-100.13	-20.11	-0.11
Comprehensive Income & Other	0.53	-0.08	0.06	-14.45	-14.28	-14.49
Total Common Equity	1,668	1,689	1,696	1,866	1,933	1,863
Minority Interest	54.88	53.2	56.72	84.18	156.4	204.62
Shareholders' Equity	1,723	1,742	1,753	1,950	2,089	2,068
Total Liabilities & Equity	2,910	2,890	2,761	3,354	3,453	3,317
Total Debt	111.56	128.05	170.99	299.1	236.94	163.57
Net Cash (Debt)	79.66	229.31	108.93	247.74	131.91	246.27
Net Cash Growth	4.04%	110.51%	-56.03%	87.80%	-46.43%	19.96%
Net Cash Per Share	0.15	0.43	0.20	0.46	0.24	0.46
Filing Date Shares Outstanding	515.17	511.74	529.15	525.69	543.85	523.63
Total Common Shares Outstanding	515.17	511.74	529.15	525.69	543.85	523.63
Working Capital	685.84	695.7	608.53	690.04	711.01	868.02
Book Value Per Share	3.24	3.30	3.21	3.55	3.55	3.56
Tangible Book Value	1,480	1,497	1,484	1,543	1,713	1,639
Tangible Book Value Per Share	2.87	2.93	2.80	2.93	3.15	3.13
Buildings	-	616.08	612.87	592.69	713.22	645.92
Machinery	-	372.33	307.03	291.68	337.87	337.91
Construction In Progress	-	-	0.21	6.19	19.02	93.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.